Our Commitments

Vector-borne diseases continue to be a major public health problem worldwide. As long as they exist, they threaten the poorest and most vulnerable populations and have the potential to resurge in times of crisis, like during pandemics. BASF keeps up the commitment to work with partners to develop and supply life-saving innovations.

Loading ...

Michael Heinz, Chairman and CEO of BASF Corporation and Member of the Board, BASF SE

Our driving force

BASF stands at the forefront of product innovation as a leader within Agricultural Solutions, exemplifying strong research and development capabilities and powerful global insecticide expertise in pursuit of the best vector-borne disease prevention. We collaborate closely with international health, government and humanitarian organizations to provide cutting-edge control products and programs to nourish and safeguard our growing population and deliver on our global health initiatives.

Sustainable Development Goals

Our vision for sustainability is to balance economic success with environmental protection and social responsibility, contributing to a future worth living for generations to come. Eradicating malaria contributes to our goals in life-changing ways. Find out how we contribute to the highlighted Sustainable Development Goals (SDGs) below.

Click on the hot spot (+) of any colored SDG icon to find out more.

Public Health challenges

Vector-borne diseases cast a shadow over progress and prosperity, disproportionately impacting children under five, creating an enduring cycle of disadvantage. We recognize the preventable nature of these diseases and have made a dedicated effort to combat and eliminate them where possible.

Malaria is a mosquito-borne infectious disease, but it is preventable and curable. Essential prevention products include Interceptor G2 mosquito nets, Fendona^® CS Controlled Release insecticide and Abate^® larvicide.

Visit the WHO Malaria Fact Sheet

Dengue fever is a viral mosquito-borne illness that can be prevented through early detection and vector control measures, such as Abate^® larvicide.

Visit the WHO Dengue Fever Fact Sheet

Yellow fever is a viral disease transmitted by mosquitoes, causing outbreaks and potentially fatal illness. Modern innovations, like Abate^® larvicide, are working to reduce the significant impact of this disease.

Visit the WHO Yellow Fever Fact Sheet

Zika virus is primarily transmitted through mosquitoes and is known to cause congenital disabilities and neurological complications. Progress has been made in preventing its spread through the use Interceptor G2 mosquito nets and Abate^® larvicide.

Visit the WHO Zika Virus Fact Sheet

A dangerous parasite spreads Guinea worm disease and causes debilitating pain, resulting in lower productivity and reduced attendance at work or school. There is no known vaccine or cure, but preventive measures include using Abate^® larvicide.

Visit the WHO Guinea Worm Fact Sheet

Innovations for the greater good

Learn more about the innovative products that play a crucial role in combating the transmission of vector-borne diseases by offering practical and effective solutions to help reduce their spread and protect vulnerable populations.

Interceptor® G2 ist das erste von der WHO empfohlene Moskitonetz mit neuem Wirkstoff, welches wirksam gegen resistenten Moskitos ist. Seine schwarz-weißen Streifen unterscheiden es von den bisher genutzten Moskitonetzen. Volker Frenz, Entwicklungschemiker für Interceptor® G2, überprüft eine Netzprobe im Labor.
Foto: Andres/BASF

Interceptor G2 mosquito nets

Public health professionals praise this long-lasting insecticide net (LLIN) as a powerful product that can help combat the negative impact of insecticide-resistant mosquitoes carrying malaria.

Fendona cs controlled release insecticide

With a low-toxicity profile, Fendona CS Controlled Release insecticide has proven safe for humans, mammals and the environment when used against malaria-bearing mosquitos, keeping insects away for up to nine months after the initial spray.

2006
Prof. Frank Hadley Collins, Dir., Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame

This 2006 photograph depicted a female <i>Aedes aegypti</i> mosquito while she was in the process of acquiring a blood meal from her human host, who in this instance, was actually the biomedical photographer, James Gathany, here at the Centers for Disease Control. You ll note the feeding apparatus consisting of a sharp, orange-colored fascicle , which while not feeding, is covered in a soft, pliant sheath called the "labellum , which retracts as the sharp stylets contained within pierce the host's skin surface, as the insect obtains its blood meal. The orange color of the fascicle is due to the red color of the blood as it migrates up the thin, sharp translucent tube.

The first reported epidemics of Dengue (DF) and dengue hemorrhagic fever (DHF) occurred in 1779-1780 in Asia, Africa, and North America. The near simultaneous occurrence of outbreaks on three continents indicates that these viruses and their mosquito vector have had a worldwide distribution in the tropics for more than 200 years. During most of this time, DF was considered a mild, nonfatal disease of visitors to the tropics. Generally, there were long intervals (10-40 years) between major epidemics, mainly because the introduction of a new serotype in a susceptible population occurred only if viruses and their mosquito vector, primarily the <i>Aedes aegypti</i> mosquito, could survive the slow transport between population centers by sailing vessels., 2006
Prof. Frank Hadley Collins, Dir., Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame

This 2006 photograph depicted a female <i>Aedes aegypti</i> mosquito while she was in the process of acquiring a blood meal from her human host, who in this instance, was actually the biomedical photographer, James Gathany, here at the Centers for Disease Control. You’ll note the feeding apparatus consisting of a sharp, orange-colored “fascicle”, which while not feeding, is covered in a soft, pliant sheath called the "labellum”, which retracts as the sharp stylets contained within pierce the host's skin surface, as the insect obtains its blood meal. The orange color of the fascicle is due to the red color of the blood as it migrates up the thin, sharp translucent tube.

The first reported epidemics of Dengue (DF) and dengue hemorrhagic fever (DHF) occurred in 1779-1780 in Asia, Africa, and North America. The near simultaneous occurrence of outbreaks on three continents indicates that these viruses and their mosquito vector have had a worldwide distribution in the tropics for more than 200 years. During most of this time, DF was considered a mild, nonfatal disease of visitors to the tropics. Generally, there were long intervals (10-40 years) between major epidemics, mainly because the introduction of a new serotype in a susceptible population occurred only if viruses and their mosquito vector, primarily the <i>Aedes aegypti</i> mosquito, could survive the slow transport between population centers by sailing vessels.

Abate larvicide

Abate larvicide prevents infected insect larvae, often in the affected population’s drinking water, from reaching maturity, breeding and spreading disease.

Harnessing the power of partnerships

Discover the incredible force behind our dynamic partnerships – the driving force behind innovation, the catalyst for lasting impact and the architect of a brighter future for communities worldwide. These powerful alliances are the foundation for groundbreaking ideas, blending diverse perspectives and expertise to unleash positive change that knows no bounds.

Our Partnerships

Work with us

Our partnerships make a significant impact in distributing life-saving nets. Join our mission to eradicate malaria and learn how you can get involved by visiting our Partnerships page or by contacting Achim Reddig. Together, we can save lives.

Achim Reddig
Global Business Management Public Health
Email | LinkedIn

Learn more

Happy schoolboy leaning his face on books and looking at camera

Media

News releases and publications

Our Stories

How we collaborate with partners

There are more than 200 million cases of malaria each year and almost half a million deaths. Infants, children under five and pregnant women are the most vulnerable groups.
Photo â Lassen/BASF
,There are more than 200 million cases of malaria each year and almost half a million deaths. Infants, children under five and pregnant women are the most vulnerable groups.
Photo – Lassen/BASF

Our Products

Find here our innovative Public Health solutions.